Umutlu L - Search Results

1

Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities.

Fendler WP, Pabst KM, Kessler L, Fragoso Costa P, Ferdinandus J, Weber M, Lippert M, Lueckerath K, Umutlu L, Kostbade K, Mavroeidi IA, Schuler M, Ahrens M, Rischpler C, Bauer S, Herrmann K, Siveke JT, Hamacher R. Fendler WP, et al. Among authors: umutlu l. Clin Cancer Res. 2022 Oct 3;28(19):4346-4353. doi: 10.1158/1078-0432.CCR-22-1432. Clin Cancer Res. 2022. PMID: 35833949 Free PMC article.

2

¹⁸F-FDG PET/MRI in patients suffering from lymphoma: how much MRI information is really needed?

Kirchner J, Deuschl C, Grueneisen J, Herrmann K, Forsting M, Heusch P, Antoch G, Umutlu L. Kirchner J, et al. Among authors: umutlu l. Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1005-1013. doi: 10.1007/s00259-017-3635-2. Epub 2017 Feb 4. Eur J Nucl Med Mol Imaging. 2017. PMID: 28161723

3

Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CT.

Kirchner J, Sawicki LM, Suntharalingam S, Grueneisen J, Ruhlmann V, Aktas B, Deuschl C, Herrmann K, Antoch G, Forsting M, Umutlu L. Kirchner J, et al. Among authors: umutlu l. PLoS One. 2017 Feb 22;12(2):e0172553. doi: 10.1371/journal.pone.0172553. eCollection 2017. PLoS One. 2017. PMID: 28225831 Free PMC article.

4

Response assessment of bevacizumab therapy in GBM with integrated 11C-MET-PET/MRI: a feasibility study.

Deuschl C, Moenninghoff C, Goericke S, Kirchner J, Köppen S, Binse I, Poeppel TD, Quick HH, Forsting M, Umutlu L, Herrmann K, Hense J, Schlamann M. Deuschl C, et al. Among authors: umutlu l. Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1285-1295. doi: 10.1007/s00259-017-3661-0. Epub 2017 Mar 3. Eur J Nucl Med Mol Imaging. 2017. PMID: 28258444

5

Imaging children suffering from lymphoma: an evaluation of different ¹⁸F-FDG PET/MRI protocols compared to whole-body DW-MRI.

Kirchner J, Deuschl C, Schweiger B, Herrmann K, Forsting M, Buchbender C, Antoch G, Umutlu L. Kirchner J, et al. Among authors: umutlu l. Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1742-1750. doi: 10.1007/s00259-017-3726-0. Epub 2017 May 22. Eur J Nucl Med Mol Imaging. 2017. PMID: 28534182

6

Integrated 18F-FDG PET/MRI compared to MRI alone for identification of local recurrences of soft tissue sarcomas: a comparison trial.

Erfanian Y, Grueneisen J, Kirchner J, Wetter A, Podleska LE, Bauer S, Poeppel T, Forsting M, Herrmann K, Umutlu L. Erfanian Y, et al. Among authors: umutlu l. Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1823-1831. doi: 10.1007/s00259-017-3736-y. Epub 2017 May 31. Eur J Nucl Med Mol Imaging. 2017. PMID: 28567495

7

18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.

Kirchner J, Sawicki LM, Deuschl C, Grüneisen J, Beiderwellen K, Lauenstein TC, Herrmann K, Forsting M, Heusch P, Umutlu L. Kirchner J, et al. Among authors: umutlu l. PLoS One. 2017 Jul 6;12(7):e0180349. doi: 10.1371/journal.pone.0180349. eCollection 2017. PLoS One. 2017. PMID: 28683109 Free PMC article.

8

Comparison of ¹⁸F-FDG PET/MRI and MRI for pre-therapeutic tumor staging of patients with primary cancer of the uterine cervix.

Sarabhai T, Schaarschmidt BM, Wetter A, Kirchner J, Aktas B, Forsting M, Ruhlmann V, Herrmann K, Umutlu L, Grueneisen J. Sarabhai T, et al. Among authors: umutlu l. Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):67-76. doi: 10.1007/s00259-017-3809-y. Epub 2017 Aug 24. Eur J Nucl Med Mol Imaging. 2018. PMID: 28840302

9

Dual-phase hybrid ¹⁸ F-Fluoride Positron emission tomography/MRI in ankylosing spondylitis: Investigating the link between MRI bone changes, regional hyperaemia and increased osteoblastic activity.

Sawicki LM, Lütje S, Baraliakos X, Braun J, Kirchner J, Boos J, Heusch P, Ruhlmann V, Herrmann K, Umutlu L, Quick HH, Antoch G, Buchbender C. Sawicki LM, et al. Among authors: umutlu l. J Med Imaging Radiat Oncol. 2018 Jun;62(3):313-319. doi: 10.1111/1754-9485.12687. Epub 2017 Oct 25. J Med Imaging Radiat Oncol. 2018. PMID: 29067775

10

Comparison of ¹⁸F-FDG PET/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer: a follow-up study.

Sawicki LM, Kirchner J, Grueneisen J, Ruhlmann V, Aktas B, Schaarschmidt BM, Forsting M, Herrmann K, Antoch G, Umutlu L. Sawicki LM, et al. Among authors: umutlu l. Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):622-629. doi: 10.1007/s00259-017-3881-3. Epub 2017 Nov 21. Eur J Nucl Med Mol Imaging. 2018. PMID: 29164299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

278 results

Search Page